Flu antiviral has bigger benefits for sicker, older patients

- EN - NL
A Europe-wide study conducted over three flu seasons finds that the antiviral drug Tamiflu can help people recover from flu-like illness about one-day sooner on average.

Published today in The Lancet, the European Commission-funded ‘ALIC4E’ study was led by the Universities of Oxford (UK) and Utrecht (The Netherlands).

Despite being stockpiled in the UK since 2006 and being widely prescribed during the swine flu outbreak in 2009, oseltamivir remains one of the most controversial drugs in use. This is due to a lack of evidence from independent clinical trials to demonstrate its effectiveness in everyday care overall, and whether it benefits key groups of patients. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.